Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02526563 · ClinicalTrials.gov registry record
Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia
A clinical trial of Alveolar Bone Grafting and Alveolar Cleft Grafting, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 4
- Enrollment target
- 1
- Study location
NCT02526563: Completed study of Alveolar Bone Grafting and Alveolar Cleft Grafting, sponsored by University of Pittsburgh.
NCT02526563 is a study of Alveolar Bone Grafting and Alveolar Cleft Grafting that has completed, run by University of Pittsburgh. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02526563, a study of Alveolar Bone Grafting and Alveolar Cleft Grafting, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary investigators in this study plan to investigate serum concentrations of ropivacaine in pediatric patients who already receive as standard of care a continuous wound catheter after an iliac crest alveolar bone graft harvest for completion of a previous cleft palate repair. The goals of this study are 1) to determine serum concentrations (free, unbound) of ropivacaine 2) To evaluate pain scores during the perioperative period to determine efficacy of wound catheters for postoperative analgesia for iliac crest bone graft harvest.
Primary Outcome
Three blood draws
Conditions Studied
Interventions
- PROCEDURE ropivicaine
Study Locations (1)
Pennsylvania
- The Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-08 |
What the finished NCT02526563 record still lists
NCT02526563 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 2 conditions, with Alveolar Bone Grafting appearing as the primary indexed condition, and to 1 intervention - of which ropivicaine is the first listed.
NCT02526563 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02526563 about?
NCT02526563 is a clinical study titled "Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia". The primary investigators in this study plan to investigate serum concentrations of ropivacaine in pediatric patients who already receive as standard of care a continuous wound catheter after an iliac crest alveolar bone graft harvest for completion of a previous cleft palate repair. The goals of t...
What is the current status of trial NCT02526563?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2015-08. Estimated completion is 2018-08.
What conditions does trial NCT02526563 study?
This clinical trial studies the following conditions: Alveolar Bone Grafting, Alveolar Cleft Grafting.
What interventions are being tested in trial NCT02526563?
The interventions under investigation include: ropivicaine (PROCEDURE).
Who is sponsoring clinical trial NCT02526563?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02526563 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alveolar Bone Grafting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia